Xeloda is the brand name for the oral chemotherapy agent capecitabine. It belongs to the oncology support category and is supplied as a 500 mg pill. In Hong Kong, Xeloda is a prescription-only medication regulated by the Department of Health.
Capecitabine is a prodrug that is converted inside the body to 5-fluorouracil (5-FU), a chemotherapy compound that interferes with DNA synthesis in rapidly dividing cancer cells. The medication is used in the treatment of several solid tumors and is taken under the close supervision of an oncologist.
5-FU inhibits the enzyme thymidylate synthase, blocking the formation of thymidine-a nucleotide required for DNA replication. The result is impaired DNA synthesis and cell death, primarily affecting rapidly dividing tumor cells while sparing most normal tissues.
Onset of therapeutic effect typically begins within a few days after starting treatment, with peak plasma concentrations of capecitabine occurring 1-2 hours after ingestion. The drug’s half-life is about 45 minutes, but the active metabolite 5-FU persists longer in tumor cells.
Capecitabine is approved by the Hong Kong Department of Health for the following indications:
These uses are based on clinical trials that demonstrated meaningful improvement in progression-free survival and overall survival when capecitabine is incorporated into standard treatment protocols.
Evidence from peer-reviewed studies and guideline panels suggests that capecitabine may be used off-label for:
Disclaimer: Off-label use of capecitabine requires careful medical supervision, individualized risk assessment, and adherence to local regulatory guidance.
If you fall into any of the contraindication categories, discuss alternative treatment options with your healthcare team.
Most of these reactions are manageable with supportive care and dose adjustments.
Any sign of a serious reaction should prompt immediate medical evaluation.
Patients should provide a complete medication list-including over-the-counter drugs, herbal supplements, and vitamins-to their oncologist before starting Xeloda.
Regular follow-up visits allow the treatment team to modify dosing, manage toxicities, and assess therapeutic effectiveness.
This article provides educational information about Xeloda (capecitabine) and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Hand-foot syndrome is managed by dose reduction, temporary drug interruption, and using soothing skin care measures such as lubricating creams and avoiding hot water or tight footwear. Report symptoms promptly to your oncologist for individualized advice.
Yes, you may travel with Xeloda, but keep the medication in its original labeled container, carry a copy of the prescription, and be prepared to show the prescription if requested by customs or airline security.
Capecitabine is not a controlled substance and is not typically screened for in routine workplace drug-testing panels. However, specialized testing can detect it if specifically requested.
There are no specific foods that must be avoided, but maintaining a balanced diet helps support overall health. Limit excessive alcohol and avoid very spicy or acidic foods if they worsen nausea.
Both deliver the same active chemotherapy (5-FU). Xeloda offers the convenience of oral administration and can be tailored to patient weight, while intravenous 5-FU provides controlled dosing in a clinical setting. Efficacy is comparable when used in appropriate regimens.
Inactivated vaccines, such as the seasonal flu shot, are generally safe for patients receiving capecitabine. Live-attenuated vaccines should be avoided. Discuss timing with your oncologist.
Herbal products can affect liver enzymes that process capecitabine. For example, St. John’s wort may increase metabolism, potentially reducing effectiveness. Always disclose any supplements to your treatment team.
Capecitabine may affect sperm production in men and ovarian function in women, especially with high cumulative doses. Discuss fertility preservation options before starting therapy if future childbearing is a concern.
Unused tablets should be returned to a pharmacy or a community drug-take-back program. Do not flush medications down the toilet or throw them in household trash, as this can contaminate the water supply.
Xeloda is a patented oncology product; price varies by pharmacy and insurance coverage. Generic capecitabine tablets of the same strength may be less expensive, but the decision to switch should be made by your oncologist based on clinical suitability.
